Trials / Completed
CompletedNCT03208673
Optive Brand For Day And Night Dry Eye Management
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an open label study of Optive eyedrops and gel combination for day and night dry eye management
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optive® Fusion + Optive® Gel Drop | Optive® Fusion eyedrop will be used as needed up to four times a day but at least twice a day. The eyedrop will be used once in the evening; the gel drop being instilled any time during the last hour prior to sleep. |
Timeline
- Start date
- 2017-07-03
- Primary completion
- 2017-09-06
- Completion
- 2017-09-06
- First posted
- 2017-07-05
- Last updated
- 2019-06-20
- Results posted
- 2019-06-20
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03208673. Inclusion in this directory is not an endorsement.